Literature DB >> 35674942

Candida auris Identification and Profiling by MALDI-ToF Mass Spectrometry.

Alireza Abdolrasouli1,2, Mark A Fraser3.   

Abstract

MALDI-ToF MS has become the standard method for routine identification of most medically important yeasts in clinical and public health laboratories and has largely replaced phenotypic identification methods as a first-line identification tool. Fungal identification is based on extensive and well-curated mass spectra libraries usually provided by the manufacturer of the MALDI-ToF MS platform; however, many centers do create specialized or in-house database collections to aid analysis. Most MALDI-ToF MS systems offer simple and standardized workflows for the identification of clinically relevant yeasts to species level with a high throughput, high accuracy, and a low overall cost per test. This makes MALDI-ToF MS an ideal platform for use in routine clinical, diagnostic, and research microbiology laboratories which may lack experience or expertise in the identification of pathogenic fungi.In this chapter we review three standard protocols for the proteomic-based identification of Candida auris isolated from cultures of clinical or environmental surveillance samples in diagnostic and research laboratories.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Candida auris; MALDI Biotyper; MALDI–ToF; Mass spectrometry

Mesh:

Year:  2022        PMID: 35674942     DOI: 10.1007/978-1-0716-2417-3_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Candida auris Isolates of the Southern Asian and South African Lineages Exhibit Different Phenotypic and Antifungal Susceptibility Profiles In Vitro.

Authors:  Adrien Szekely; Andrew M Borman; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

2.  Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database.

Authors:  Mark Fraser; Zoe Brown; Marian Houldsworth; Andrew M Borman; Elizabeth M Johnson
Journal:  Med Mycol       Date:  2015-11-21       Impact factor: 4.076

3.  Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris.

Authors:  Johanna Rhodes; Alireza Abdolrasouli; Rhys A Farrer; Christina A Cuomo; David M Aanensen; Darius Armstrong-James; Matthew C Fisher; Silke Schelenz
Journal:  Emerg Microbes Infect       Date:  2018-03-29       Impact factor: 7.163

4.  Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species.

Authors:  José F Muñoz; Lalitha Gade; Nancy A Chow; Vladimir N Loparev; Phalasy Juieng; Elizabeth L Berkow; Rhys A Farrer; Anastasia P Litvintseva; Christina A Cuomo
Journal:  Nat Commun       Date:  2018-12-17       Impact factor: 14.919

5.  Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species.

Authors:  Andrew M Borman; Adrien Szekely; Elizabeth M Johnson
Journal:  mSphere       Date:  2016-08-18       Impact factor: 4.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.